Welcome to LookChem.com Sign In|Join Free

CAS

  • or

916219-96-0

C25H22F3NO4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

916219-96-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 916219-96-0 Structure

  • Basic information

    1. Product Name: C25H22F3NO4
    2. Synonyms: C25H22F3NO4
    3. CAS NO:916219-96-0
    4. Molecular Formula:
    5. Molecular Weight: 457.449
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 916219-96-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C25H22F3NO4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C25H22F3NO4(916219-96-0)
    11. EPA Substance Registry System: C25H22F3NO4(916219-96-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 916219-96-0(Hazardous Substances Data)

916219-96-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 916219-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,2,1 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 916219-96:
(8*9)+(7*1)+(6*6)+(5*2)+(4*1)+(3*9)+(2*9)+(1*6)=180
180 % 10 = 0
So 916219-96-0 is a valid CAS Registry Number.

916219-96-0Relevant articles and documents

Optimization of GPR40 agonists for type 2 diabetes

Liu, Jiwen,Wang, Yingcai,Ma, Zhihua,Schmitt, Mike,Zhu, Liusheng,Brown, Sean P.,Dransfield, Paul J.,Sun, Ying,Sharma, Rajiv,Guo, Qi,Zhuang, Run,Zhang, Jane,Luo, Jian,Tonn, George R.,Wong, Simon,Swaminath, Gayathri,Medina, Julio C.,Lin, Daniel C.-H.,Houze, Jonathan B.

, p. 517 - 521 (2014/06/09)

GPR40 (FFA1 and FFAR1) has gained significant interest as a target for the treatment of type 2 diabetes. TAK-875 (1), a GPR40 agonist, lowered hemoglobin A1c (HbA1c) and lowered both postprandial and fasting blood glucose levels in type 2 diabetic patient

Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

-

Page/Page column 45, (2008/06/13)

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L1, L2, M, X, L3, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders

-

Page/Page column 21, (2008/06/13)

The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally substituted thiazole r

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 916219-96-0